We are live on
!
Find out more
TI
Telemetry Investments Portfolio holdings
AUM
$63.3M
1-Year Est. Return
0.06%
This Fund
S&P 500
This Quarter
Est. Return
-4.19%
1 Year Est. Return
+0.06%
3 Year Est. Return
+77.42%
5 Year Est. Return
+156.79%
10 Year Est. Return
–
AUM
$129M
AUM Growth
-$67.4M
(-34%)
Cap. Flow
-$60.9M
Cap. Flow
% of AUM
-47.04%
Top 10 Holdings %
Top 10 Hldgs %
62.88%
Holding
130
New
32
Increased
19
Reduced
25
Closed
48
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
EIGR
Eiger BioPharmaceuticals, Inc.
EIGR
|
+$2.7M |
| 2 |
VSM
Versum Materials, Inc.
VSM
|
+$2.12M |
| 3 |
WCG
Wellcare Health Plans, Inc.
WCG
|
+$2.07M |
| 4 |
WBC
WABCO HOLDINGS INC.
WBC
|
+$1.4M |
| 5 |
ZSAN
Zosano Pharma Corporation
ZSAN
|
+$1.32M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
IDTI
Integrated Device Technology I
IDTI
|
+$2.41M |
| 2 |
ELLI
Ellie Mae Inc
ELLI
|
+$1.64M |
| 3 |
USG
Usg
USG
|
+$816K |
| 4 |
ARRS
ARRIS International plc Ordinary Shares
ARRS
|
+$790K |
| 5 |
SBBP
Strongbridge Biopharma plc.
SBBP
|
+$620K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 15.35% |
| 2 | Communication Services | 3.27% |
| 3 | Materials | 2.17% |
| 4 | Technology | 1.98% |
| 5 | Industrials | 1.73% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
BRSS
26
DELISTED
Global Brass & Copper Hldgs, Inc
BRSS
| $937K | 0.72% |
+21,433
| New | +$912K |
|
27
PUT
Uber
UBER
$144B
| $928K | 0.72% |
+20,000
| New | +$849K |
|
|
EE
28
DELISTED
El Paso Electric Company
EE
| $850K | 0.66% |
+13,000
| New | +$798K |
|
|
DERM
29
DELISTED
Dermira, Inc.
DERM
| $760K | 0.59% |
+79,500
| New | +$856K |
|
30
Globalstar
GSAT
$10.2B
| $736K | 0.57% |
102,199
+8,765
| +9% | +$68.6K |
|
|
VRAY
31
DELISTED
ViewRay, Inc.
VRAY
| $683K | 0.53% |
77,500
-22,500
| -23% | -$183K |
|
|
FNSR
32
DELISTED
Finisar Corp
FNSR
| $640K | 0.49% |
28,000
+7,000
| +33% | +$160K |
|
|
MLNX
33
DELISTED
Mellanox Technologies, Ltd.
MLNX
| $625K | 0.48% |
+5,645
| New | +$650K |
|
34
Rigel Pharmaceuticals
RIGL
$712M
| $611K | 0.47% |
23,400
-6,600
| -22% | -$149K |
|
|
VRAY
35
CALL
DELISTED
ViewRay, Inc.
VRAY
| $608K | 0.47% |
69,000
-63,500
| -48% | -$516K |
|
|
S
36
DELISTED
Sprint Corporation
S
| $608K | 0.47% |
92,500
-23,497
| -20% | -$148K |
|
37
CALL
Novavax
NVAX
$1.21B
| $586K | 0.45% |
+100,000
| New | +$787K |
|
|
CELG
38
DELISTED
Celgene Corp
CELG
| $573K | 0.44% |
+6,200
| New | +$589K |
|
|
STML
39
DELISTED
Stemline Therapeutics, Inc.
STML
| $521K | 0.4% |
34,000
-16,000
| -32% | -$231K |
|
|
LEXEA
40
DELISTED
Liberty Expedia Holdings, Inc. Class A Common Stock
LEXEA
| $521K | 0.4% |
+10,900
| New | +$481K |
|
|
ZAYO
41
DELISTED
Zayo Group Holdings, Inc.
ZAYO
| $510K | 0.39% |
+15,500
| New | +$495K |
|
42
Matinas BioPharma
MTNB
$1.88M
| $492K | 0.38% |
11,492
-1,508
| -12% | -$72.5K |
|
|
TCON
43
DELISTED
TRACON Pharmaceuticals, Inc. Common Stock
TCON
| $468K | 0.36% |
3,438
+477
| +16% | +$75.4K |
|
44
Newmont
NEM
$96.4B
| $445K | 0.34% |
+11,576
| New | +$391K |
|
|
VRAY
45
PUT
DELISTED
ViewRay, Inc.
VRAY
| $440K | 0.34% |
50,000
| – | – |
|
46
ADMA Biologics
ADMA
$2.04B
| $430K | 0.33% |
+111,005
| New | +$490K |
|
|
SRRA
47
DELISTED
Sierra Oncology, Inc. Common Stock
SRRA
| $422K | 0.33% |
18,856
+15,928
| +544% | +$771K |
|
48
Aclaris Therapeutics
ACRS
$744M
| $415K | 0.32% |
189,530
+40,526
| +27% | +$221K |
|
49
Goldman Sachs
GS
$305B
| $409K | 0.32% |
+2,000
| New | +$396K |
|
50
Boeing
BA
$175B
| $400K | 0.31% |
1,100
-700
| -39% | -$255K |
|
Similar funds
SF
CAM
SCFS
LCH
SGMPI
HJMC
AI
DFAM
Telemetry Investments's Q2 2019 Portfolio in Review
As of Q2 2019, Telemetry Investments held 130 positions worth $129M, down 34% from $197M the previous quarter. Its ten largest holdings account for 63% of the portfolio.
Telemetry Investments withdrew a net $60.9M in Q2 2019, closing 48 positions and reducing 25 holdings. Its most notable exit was Integrated Device Technology I, an estimated $2.41M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 15% of assets, up from 10% a quarter earlier, followed by Communication Services and Materials.
Against the trend, Telemetry Investments opened a new position in Versum Materials, Inc. worth $2.12M.
- Telemetry Investments's largest Q2 2019 buy was Versum Materials, Inc.: 41,000 shares worth $2.12M.
- Telemetry Investments added most to Eiger BioPharmaceuticals, Inc. in Q2 2019, an estimated $2.7M increase.
- Telemetry Investments's biggest Q2 2019 reduction was Rosehill Resources Inc. Class A, cutting an estimated $524K.
- Telemetry Investments fully exited Integrated Device Technology I in Q2 2019, selling an estimated $2.41M.
- Telemetry Investments's ten largest holdings make up 63% of its $129M portfolio in Q2 2019.
- Telemetry Investments opened 32 new positions and closed 48 in Q2 2019.
- Telemetry Investments's portfolio value fell 34% quarter-over-quarter to $129M.
Based on Telemetry Investments's 13F filing for Q2 2019, filed 14 Aug 2019.